Tilray: Fourth Quarter Consensus Estimates

Tilray (TSX: TLRY) (NASDAQ: TLRY) will be reporting its fourth quarter financial results on July 28 before the market opens. Analysts have a consensus $17.77 12-month price target on the company, via a total of 20 analysts, with 2 analysts having strong buy ratings. 3 analysts meanwhile have buy ratings, 14 have hold ratings and a single analyst has a sell rating on the company. The street high comes from Roth Capital with a $25 price target, and the lowest target sits at $1.27 from GLJ Research.

10 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 10 analysts is $146.19 million; this number has been revised upwards from $71.20 million at the start of the year. The highest revenue estimate is $175.4 million, while the lowest is $107.62 million.

Onto EBITDA estimates, there are currently 7 analysts who have fourth-quarter EBITDA estimates. The mean is currently $5.81 million, with this number being flat since the start of the year. The street high estimate currently sits at $11.7 million in EBITDA and the lowest is -$2.83 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Crossroads Gold Begins 2026 Exploration at Pambula, Reports Gold In Soil Up to 24.6 g/t

Questcorp Kicks Off Fully Funded Phase 2 Drilling at La Union

Related News

Alphabet: Third Quarter 2021 Earnings Preview

Alphabet (NASDAQ: GOOGL) will be reporting its third quarter financial results on October 26th after...

Tuesday, October 26, 2021, 11:17:00 AM

MAG Silver: BMO Lowers Target To $23.50 After Delays

On December 27th, MAG Silver (TSX: MAG) provided an update on the Juanicipio project. MAG...

Thursday, January 6, 2022, 02:52:00 PM

Antibe: Canaccord Raises Price Target After Q4 Results

On June 28th, Antibe Therapeutics (TSX: ATE) reported their fourth quarter and year-end financials. The...

Friday, July 2, 2021, 12:18:00 PM

Merger Of The Greats: Stifel Provides Green Thumb, Trulieve Merger Rumour Thoughts

In a note sent to investors this morning, Andrew Partheniou of Stifel GMP headlined, “A...

Thursday, August 27, 2020, 01:31:38 PM

Organigram: Haywood Raises Estimates Betting On Increased Market Share

On January 11th, Organigram Holdings (TSX: OGI) issued its second fiscal quarter earnings for 2022....

Saturday, January 15, 2022, 11:09:00 AM